D-0651-2017 Class III Terminated
FDA drug recall D-0651-2017 was initiated by West-Ward Columbus, Inc. on Apr 4, 2017 and is designated Class III. Reason for recall: Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print. The recall status is terminated (terminated Sep 4, 2018). Affected quantity: 100 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 19, 2017
- Initiation Date
- Apr 4, 2017
- Termination Date
- Sep 4, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 100 bottles
Product description
Doxercalciferol Capsules 0.5mcg, 50 count bottles, Rx, only, Manufactured by Cipla Limited Kurkumbh, Maharashtra, India, Manufactured for West-Ward, Pharmaceuticals, Corp., Eatontown, NJ -- NDC 0054-0338-19
Reason for recall
Failed Tablet/Capsule Specifications; during an internal inspection, capsules were found with illegible print.
Distribution pattern
The recalled product was distributed to the following state: OH. There are no Canada accounts for this recall. There are no Mexico accounts for this recall. There are no government accounts for this recall.
Code information
Lot KB60707, 10/31/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0651-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026